See related Micardis Plus information |
|
Manufacturer |
Boehringer Ingelheim |
Distributor |
Hong Kong: Zuellig/Macau: Agencia Lei Va Hong |
Contents |
Per 40/12.5 mg tab Telmisartan 40 mg, hydrochlorothiazide 12.5 mg. Per 80/12.5 mg tab Telmisartan 80 mg, hydrochlorothiazide 12.5 mg. Per 80/25 mg tab Telmisartan 80 mg, hydrochlorothiazide 25 mg |
Indications |
Treatment of essential HTN in patients whose BP is not adequately controlled on telmisartan alone.
Click to view Micardis Plus detailed prescribing infomation |
Dosage |
Adult 1 tab once daily w/ liqd. Mild to moderate hepatic impairment Max: 1 40/12.5 mg tab daily.
Click to view Micardis Plus detailed prescribing infomation |
Overdosage |
View Micardis Plus overdosage for action to be taken in the event of an overdose. |
Administration |
May be taken with or without food |
Contraindications |
Hypersensitivity to other sulphonamide-derived drugs. Pregnancy (2nd & 3rd trimesters) & lactation. Cholestasis & biliary obstructive disorders. Severe hepatic & renal (CrCl <30 mL/min) impairment. Refractory hypokalaemia, hypercalcaemia.
Click to view Micardis Plus detailed prescribing infomation |
Special Precautions |
Impaired hepatic function or progressive liver disease. Bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney. Mild to moderate renal impairment & kidney transplantation. Vol &/or Na depletion. Severe CHF or underlying renal disease including renal artery stenosis. Primary aldosteronism. Aortic or mitral valve stenosis, obstructive hypertrophic cardiomyopathy. Hypokalaemia, hyperkalaemia, hyponatraemia & hypochloraemic alkalosis, hypercalcaemia, hypomagnesaemia. Diabetes. Hereditary fructose &/or galactose intolerance.
Click to view Micardis Plus detailed prescribing infomation |
Adverse Drug Reactions |
Dizziness; hypokalaemia, anxiety, syncope, paraesthesia, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnoea, diarrhoea, dry mouth, flatulence, back pain, muscle spasms, myalgia, erectile dysfunction, chest pain, increased blood uric acid.
View ADR Monitoring Form |
Drug Interactions |
Lithium, digitalis glycosides, other antihypertensive agents, alcohol, barbiturates, narcotics or antidepressants, baclofen, amifostine, oral antidiabetic agents & insulin, metformin, cholestyramine & colestipol resins, NSAIDs, pressor amines, nondepolarizing skeletal muscle relaxants, probenecid, sulfinpyrazone & allopurinol, Ca salts, β-blockers & diazoxide, anticholinergic agents, amantadine, cytotoxic agents. Drugs associated w/ K loss & hypokalaemia. Drugs that may increase K levels or induce hyperkalaemia. Drugs affected by serum K disturbances.
View more drug interactions with Micardis Plus |
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). |
Storage |
View Micardis Plus storage conditions for details to ensure optimal shelf-life. |
Description |
View Micardis Plus description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View Micardis Plus mechanism of action for pharmacodynamics and pharmacokinetics details. |
Presentation/Packing |
Form |
Packing |
Photo |
Micardis Plus 40/12.5 mg tablet |
Micardis Plus 30's |
 |
|
Micardis Plus 80/12.5 mg tablet |
Micardis Plus 30's |
 |
|
Micardis Plus 80/25 mg tablet |
|
|
Manufacturer: |
Boehringer Ingelheim |
Distributor: |
Hong Kong: Zuellig
Macau: Agencia Lei Va Hong
|
|
|
|